Solventum Corporation
Solventum Corporation (SOLV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SOLV · as of Jun 8, 2026
Key Statistics
Explore Solventum Corporation Data
solv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 63.6%
The SOLV analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $84.29, representing +4.05% upside from the current price of $81.01.
Competitors & Peers
solv competitorsSOLV
ALGN
DOCS
EHC
ELAN
ENSGStock Performance
Full HistoryAbout Solventum Corporation
Solventum Corporation a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through …
what is solventum corporation · solv stock overview · solventum corporation company profile · who is solventum corporation ceo · solv NYSE · solventum corporation headquarters · solventum corporation business segments
About Stock Overview & Key Data
Solventum Corporation (SOLV) is a Healthcare company in the Medical - Care Facilities industry, listed on NYSE since Apr 1, 2024. As of the latest trading session, SOLV stock price is $81.01, with a market capitalization of $14.0B. The stock has returned +8.13% over the past 12 months and +2.23% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Solventum Corporation stock is Buy, with an average 12-month price target of $84.29. In fiscal year 2025, Solventum Corporation reported revenue of $8.3B and net income of $1.6B. For detailed data — including Solventum Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Solventum Corporation (SOLV) stock price is $81.01. The stock is traded on NYSE under the ticker symbol SOLV. The 52-week range is $62.38 – $88.20.